Blood Cancer Diagnostics Market
Blood Cancer Diagnostics Market By Test (CBC Tests for Blood Cancer Diagnostics, CTC Tests for Blood Cancer Diagnostics, Blood Protein Testing for Blood Cancer Diagnostics, Liquid Biopsy for Blood Cancer Diagnostics), By End User- Forecast to 2021–2031
- Mar-2022
- List of Tables : 165
- List of Figures : 57
- 170 Pages
- Healthcare
Table of Content
Chapter 1. Global Blood Cancer Diagnostics Market - Executive Summary
Chapter 2. Global Blood Cancer Diagnostics Market Overview
2.1. Introduction
2.1.1. Global Blood Cancer Diagnostics Market Taxonomy
2.1.2. Global Blood Cancer Diagnostics Market Definition
2.2. Global Blood Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2016-2031
2.2.1. Global Blood Cancer Diagnostics Market Y-o-Y Growth
2.3. Global Blood Cancer Diagnostics Market Dynamics
2.3.1. Drivers
2.3.2. Restraints
2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. List of Distributors
2.7. Average Pricing Analysis
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region
Chapter 3. Global Blood Cancer Diagnostics Market Analysis and Forecast By Test Type
3.1. Global Blood Cancer Diagnostics Market Size and Forecast By Test Type, 2016-2031
3.1.1. CBC Tests Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. CTC Tests Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
3.1.3. Blood Protein Testing Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
3.1.3.1. Revenue (US$ Mn) Comparison, By Region
3.1.3.2. Market Share Comparison, By Region
3.1.3.3. Y-o-Y growth Comparison, By Region
3.1.4. Liquid Biopsy Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
3.1.4.1. Revenue (US$ Mn) Comparison, By Region
3.1.4.2. Market Share Comparison, By Region
3.1.4.3. Y-o-Y growth Comparison, By Region
3.1.5. Bone Marrow Biopsy Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
3.1.5.1. Revenue (US$ Mn) Comparison, By Region
3.1.5.2. Market Share Comparison, By Region
3.1.5.3. Y-o-Y growth Comparison, By Region
3.1.6. Others Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
3.1.6.1. Revenue (US$ Mn) Comparison, By Region
3.1.6.2. Market Share Comparison, By Region
3.1.6.3. Y-o-Y growth Comparison, By Region
Chapter 4. Global Blood Cancer Diagnostics Market Analysis and Forecast By End User
4.1. Global Blood Cancer Diagnostics Market Size and Forecast By End User, 2016-2031
4.1.1. Hospital Associated Labs Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Independent Diagnostic Laboratories Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Cancer Research Institutes Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Others Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
Chapter 5. Global Blood Cancer Diagnostics Market Analysis and Forecast By Region
5.1. Global Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
5.1.1. North America Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.1.2. Revenue (US$ Mn) Comparison, By End User
5.1.2. Latin America Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.2.2. Revenue (US$ Mn) Comparison, By End User
5.1.3. Europe Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.3.2. Revenue (US$ Mn) Comparison, By End User
5.1.4. Japan Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.4.2. Revenue (US$ Mn) Comparison, By End User
5.1.5. APEJ Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.5.2. Revenue (US$ Mn) Comparison, By End User
5.1.6. MEA Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.6.2. Revenue (US$ Mn) Comparison, By End User
Chapter 6. North America Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031
6.1. US Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
6.1.1. Revenue (US$ Mn) Comparison, By Test Type
6.1.2. Revenue (US$ Mn) Comparison, By End User
6.2. Canada Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
6.2.1. Revenue (US$ Mn) Comparison, By Test Type
6.2.2. Revenue (US$ Mn) Comparison, By End User
Chapter 7. Latin America Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031
7.1. Brazil Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
7.1.1. Revenue (US$ Mn) Comparison, By Test Type
7.1.2. Revenue (US$ Mn) Comparison, By End User
7.2. Mexico Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
7.2.1. Revenue (US$ Mn) Comparison, By Test Type
7.2.2. Revenue (US$ Mn) Comparison, By End User
7.3. Argentina Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
7.3.1. Revenue (US$ Mn) Comparison, By Test Type
7.3.2. Revenue (US$ Mn) Comparison, By End User
Chapter 8. Europe Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031
8.1. Germany Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
8.1.1. Revenue (US$ Mn) Comparison, By Test Type
8.1.2. Revenue (US$ Mn) Comparison, By End User
8.2. UK Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
8.2.1. Revenue (US$ Mn) Comparison, By Test Type
8.2.2. Revenue (US$ Mn) Comparison, By End User
8.3. France Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
8.3.1. Revenue (US$ Mn) Comparison, By Test Type. 858.3.2. Revenue (US$ Mn) Comparison, By End User
8.4. Spain Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
8.4.1. Revenue (US$ Mn) Comparison, By Test Type
8.4.2. Revenue (US$ Mn) Comparison, By End User
8.5. Italy Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
8.5.1. Revenue (US$ Mn) Comparison, By Test Type
8.5.2. Revenue (US$ Mn) Comparison, By End User
8.6. Nordic Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
8.6.1. Revenue (US$ Mn) Comparison, By Test Type
8.6.2. Revenue (US$ Mn) Comparison, By End User
Chapter 9. Japan Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031
9.1. Japan Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
9.1.1. Revenue (US$ Mn) Comparison, By Test Type
9.1.2. Revenue (US$ Mn) Comparison, By End User
Chapter 10. APEJ Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031
10.1. China Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
10.1.1. Revenue (US$ Mn) Comparison, By Test Type
10.1.2. Revenue (US$ Mn) Comparison, By End User
10.2. India Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
10.2.1. Revenue (US$ Mn) Comparison, By Test Type
10.2.2. Revenue (US$ Mn) Comparison, By End User
10.3. Malaysia Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
10.3.1. Revenue (US$ Mn) Comparison, By Test Type
10.3.2. Revenue (US$ Mn) Comparison, By End User
10.4. Thailand Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
10.4.1. Revenue (US$ Mn) Comparison, By Test Type
10.4.2. Revenue (US$ Mn) Comparison, By End User
10.5. Singapore Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
10.5.1. Revenue (US$ Mn) Comparison, By Test Type
10.5.2. Revenue (US$ Mn) Comparison, By End User
10.6. Australia Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
10.6.1. Revenue (US$ Mn) Comparison, By Test Type
10.6.2. Revenue (US$ Mn) Comparison, By End User
Chapter 11. MEA Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031
11.1. GCC Countries Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
11.1.1. Revenue (US$ Mn) Comparison, By Test Type
11.1.2. Revenue (US$ Mn) Comparison, By End User
11.2. South Africa Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
11.2.1. Revenue (US$ Mn) Comparison, By Test Type
11.2.2. Revenue (US$ Mn) Comparison, By End User
11.3. Nigeria Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
11.3.1. Revenue (US$ Mn) Comparison, By Test Type
11.3.2. Revenue (US$ Mn) Comparison, By End User
11.4. Israel Blood Cancer Diagnostics Market Size and Forecast, 2016-2031
11.4.1. Revenue (US$ Mn) Comparison, By Test Type
11.4.2. Revenue (US$ Mn) Comparison, By End User
Chapter 12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Overview
12.1.3. Key Financials
12.1.4. Key Developments
12.2. Roche Holding AG.
12.2.1. Company Overview
12.2.2. Product Overview
12.2.3. Key Financials.
12.3. Thermo Fisher Scientific Inc.
12.3.1. Company Overview
12.3.2. Product Overview
12.3.3. Key Financials
12.3.4. SWOT Analysis
12.3.5. Key Developments
12.4. Laboratory Corporation Of America Holdings
12.4.1. Company Overview
12.4.2. Product Overview
12.4.3. Key Financials.
12.5. Luminex Corporation
12.5.1. Company Overview
12.5.2. Product Overview
12.5.3. Key Financials
12.6. Myriad Genetics Inc
12.6.1. Company Overview
12.6.2. Key Financials
12.6.3. SWOT Analysis
12.7. NanoString Technologies Inc
12.7.1. Company Overview.
12.7.2. Product Overview.
12.7.3. Key Financials.
12.8. NeoGenomics Laboratories, Inc.
12.8.1. Company Overview
12.8.2. Key Financials.
12.9. Siemens AG
12.9.1. Company Overview
12.9.2. Key Financials
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.10. Quest Diagnostics Incorporated
12.10.1. Company Overview
12.10.2. Product Overview
12.10.3. Key Financials.
12.10.4. SWOT Analysis.
12.11. QIAGEN N.V.
12.11.1. Company Overview
12.11.2. Product Overview
12.11.3. Key Financials
12.12. Agilent Technologies
12.12.1. Company Overview
12.12.2. Product Overview
12.12.3. Key Financials.
12.12.4. Key Developments
12.12.5. SWOT Analysis
12.13. Biotheranostics, Inc
12.13.1. Company Overview
12.13.2. Product Overview
12.14. Almac Group Limited. 145
12.14.1. Company Overview
12.14.2. Product Overview
12.15. GeneNews Limited. 146
12.15.1. Company Overview
12.15.2. Product Overview
Chapter 13. Disclaimer and Contact information
Know More Details About the Report
List of Tables
TABLE 1 Global Blood Cancer Diagnostics Market Value (US$ Mn), 2016-2020
TABLE 2 Global Blood Cancer Diagnostics Market Value (US$ Mn), 2021-2031
TABLE 3 Global Blood Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2031
TABLE 4 Global CBC Tests Segment Value (US$ Mn), By Region 2016-2020
TABLE 5 Global CBC Tests Segment Value (US$ Mn), By Region 2021-2031
TABLE 6 Global CBC Tests Segment Market Share, By Region 2016-2020
TABLE 7 Global CBC Tests Segment Market Share, By Region 2021-2031
TABLE 8 Global CBC Tests Segment Y-o-Y, By Region 2015-2031
TABLE 9 Global CTC Tests Segment Value (US$ Mn), By Region 2016-2020
TABLE 10 Global CTC Tests Segment Value (US$ Mn), By Region 2021-2031
TABLE 11 Global CTC Tests Segment Market Share, By Region 2016-2020
TABLE 12 Global CTC Tests Segment Market Share, By Region 2021-2031
TABLE 13 Global CTC Tests Segment Y-o-Y, By Region 2015-2031
TABLE 14 Global Blood Protein Testing Segment Value (US$ Mn), By Region 2016-2020
TABLE 15 Global Blood Protein Testing Segment Value (US$ Mn), By Region 2021-2031
TABLE 16 Global Blood Protein Testing Segment Market Share, By Region 2016-2020
TABLE 17 Global Blood Protein Testing Segment Market Share, By Region 2021-2031
TABLE 18 Global Blood Protein Testing Segment Y-o-Y, By Region 2015-2031
TABLE 19 Global Liquid Biopsy Segment Value (US$ Mn), By Region 2016-2020
TABLE 20 Global Liquid Biopsy Segment Value (US$ Mn), By Region 2021-2031
TABLE 21 Global Liquid Biopsy Segment Market Share, By Region 2016-2020
TABLE 22 Global Liquid Biopsy Segment Market Share, By Region 2021-2031
TABLE 23 Global Liquid Biopsy Segment Y-o-Y, By Region 2015-2031
TABLE 24 Global Bone Marrow Biopsy Segment Value (US$ Mn), By Region 2016-2020
TABLE 25 Global Bone Marrow Biopsy Segment Value (US$ Mn), By Region 2021-2031
TABLE 26 Global Bone Marrow Biopsy Segment Market Share, By Region 2016-2020
TABLE 27 Global Bone Marrow Biopsy Segment Market Share, By Region 2021-2031
TABLE 28 Global Bone Marrow Biopsy Segment Y-o-Y, By Region 2015-2031
TABLE 29 Global Others Segment Value (US$ Mn), By Region 2016-2020
TABLE 30 Global Others Segment Value (US$ Mn), By Region 2021-2031
TABLE 31 Global Others Segment Market Share, By Region 2016-2020
TABLE 32 Global Others Segment Market Share, By Region 2021-2031
TABLE 33 Global Others Segment Y-o-Y, By Region 2015-2031
TABLE 34 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2016-2020
TABLE 35 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2021-2031
TABLE 36 Global Hospital Associated Labs Segment Market Share, By Region 2016-2020
TABLE 37 Global Hospital Associated Labs Segment Market Share, By Region 2021-2031
TABLE 38 Global Hospital Associated Labs Segment Y-o-Y, By Region 2015-2031
TABLE 39 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2016-2020
TABLE 40 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2021-2031
TABLE 41 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2016-2020
TABLE 42 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2021-2031
TABLE 43 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2015-2031
TABLE 44 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2016-2020
TABLE 45 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2021-2031
TABLE 46 Global Cancer Research Institutes Segment Market Share, By Region 2016-2020
TABLE 47 Global Cancer Research Institutes Segment Market Share, By Region 2021-2031
TABLE 48 Global Cancer Research Institutes Segment Y-o-Y, By Region 2015-2031
TABLE 49 Global Others Segment Value (US$ Mn), By Region 2016-2020
TABLE 50 Global Others Segment Value (US$ Mn), By Region 2021-2031
TABLE 51 Global Others Segment Market Share, By Region 2016-2020
TABLE 52 Global Others Segment Market Share, By Region 2021-2031
TABLE 53 Global Others Segment Y-o-Y, By Region 2015-2031
TABLE 54 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 55 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 56 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 57 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 58 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 59 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 60 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 61 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 62 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 63 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 64 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 65 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 66 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 67 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 68 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 69 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 70 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 71 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 72 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 73 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 74 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 75 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 76 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 77 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 78 US Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 79 US Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 80 US Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 81 US Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 82 Canada Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 83 Canada Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 84 Canada Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 85 Canada Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 86 Brazil Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 87 Brazil Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 88 Brazil Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 89 Brazil Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 90 Mexico Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 91 Mexico Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 92 Mexico Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 93 Mexico Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 94 Argentina Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 95 Argentina Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 96 Argentina Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 97 Argentina Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 98 Germany Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 99 Germany Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 100 Germany Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 101 Germany Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 102 UK Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 103 UK Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 104 UK Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 105 UK Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 106 France Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 107 France Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 108 France Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 109 France Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 110 Spain Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 111 Spain Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 112 Spain Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 113 Spain Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 114 Italy Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 115 Italy Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 116 Italy Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 117 Italy Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 118 Nordic Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 119 Nordic Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 120 Nordic Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 121 Nordic Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 122 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 123 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 124 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 125 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 126 China Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 127 China Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 128 China Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 129 China Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 130 India Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 131 India Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 132 India Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 133 India Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 134 Malaysia Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 135 Malaysia Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 136 Malaysia Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 137 Malaysia Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 138 Thailand Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 139 Thailand Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 140 Thailand Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 141 Thailand Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 142 Singapore Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 143 Singapore Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 144 Singapore Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 145 Singapore Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 146 Australia Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 147 Australia Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 148 Australia Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 149 Australia Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 150 GCC Countries Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 151 GCC Countries Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 152 GCC Countries Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 153 GCC Countries Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 154 South Africa Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 155 South Africa Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 156 South Africa Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 157 South Africa Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 158 Nigeria Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 159 Nigeria Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 160 Nigeria Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 161 Nigeria Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
TABLE 162 Israel Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 163 Israel Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
TABLE 164 Israel Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 165 Israel Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 1 Global Blood Cancer Diagnostics Market Value (US$ Mn), 2016-2020
FIG. 2 Global Blood Cancer Diagnostics Market Value (US$ Mn) Forecast, 2021-2031
FIG. 3 Global Blood Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2031
FIG. 4 Global CBC Tests Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 5 Global CBC Tests Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 6 Global CBC Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 7 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 8 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 9 Global CTC Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 10 Global Blood Protein Testing Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 11 Global Blood Protein Testing Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 12 Global Blood Protein Testing Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 13 Global Liquid Biopsy Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 14 Global Liquid Biopsy Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 15 Global Liquid Biopsy Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 16 Global Bone Marrow Biopsy Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 17 Global Bone Marrow Biopsy Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 18 Global Bone Marrow Biopsy Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 19 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 20 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 21 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 22 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 23 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 24 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 25 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 26 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 27 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 28 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 29 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 30 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 31 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 50
FIG. 32 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 51
FIG. 33 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031 53
FIG. 34 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 35 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 36 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 37 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 38 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 39 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 40 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 41 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 42 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 43 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 44 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 45 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 46 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 47 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 48 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 49 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 50 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 51 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 52 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 53 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 54 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 55 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 56 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 57 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
Have a report related query? Speak to us directly
List of Figures
FIG. 1 Global Blood Cancer Diagnostics Market Value (US$ Mn), 2016-2020
FIG. 2 Global Blood Cancer Diagnostics Market Value (US$ Mn) Forecast, 2021-2031
FIG. 3 Global Blood Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2031
FIG. 4 Global CBC Tests Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 5 Global CBC Tests Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 6 Global CBC Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031 25
FIG. 7 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 8 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 9 Global CTC Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 10 Global Blood Protein Testing Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 11 Global Blood Protein Testing Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 12 Global Blood Protein Testing Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 13 Global Liquid Biopsy Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 14 Global Liquid Biopsy Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 15 Global Liquid Biopsy Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 16 Global Bone Marrow Biopsy Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 17 Global Bone Marrow Biopsy Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 18 Global Bone Marrow Biopsy Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 19 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 20 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 21 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 22 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 23 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 24 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 25 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 26 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 27 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 28 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 29 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 30 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 31 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 32 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031
FIG. 33 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031
FIG. 34 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 35 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 36 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 37 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 38 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 39 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 40 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 41 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 42 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 43 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 44 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 45 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 46 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 47 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 48 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 49 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 50 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 51 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 52 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 53 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
FIG. 54 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 55 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031
FIG. 56 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 57 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031
Blood Cancer Diagnostics Market - Scope of Report
A recent study by Fact.MR on the blood cancer diagnostics market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with the development of Blood cancer Diagnostics.
The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, cost structure analysis, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies manufacturing blood cancer diagnostic products, along with their product portfolios, key strategies, and SWOT analysis, enhances the reliability of this comprehensive research study.
Report Summary
The study offers comprehensive analysis on diverse features, including revenue growth, product enhancements, and revenue generation from blood cancer diagnostics across the globe.
A comprehensive estimate on the market has been provided through an optimistic scenario as well as a conservative scenario, taking into account revenue through blood cancer diagnostics during the forecast period.
Analysis on Market Size Evaluation
The market has been analyzed for each market segment in terms of volume (units), and value (US$ Mn).
Market estimates at global and regional levels for blood cancer diagnostics are available in terms of “US$ Mn”. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a company can look to achieve, along with identifying potential resources, considering the revenue perspective in the global blood cancer diagnostics market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include market forces analysis, which is expected to have a momentous influence on the growth of the blood cancer diagnostics industry during the forecast period.
Country-specific valuation on revenue for blood cancer diagnostics has been offered for each regional market, along with market scope estimates and forecasts, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value for key countries has also been included in the report.
In-depth Analysis on Competition
The report sheds light on leading providers of blood cancer diagnostics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in blood cancer diagnostics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the blood cancer diagnostics market.
- FAQs -
Over the decade, demand for blood cancer diagnostics is anticipated to increase at a healthy CAGR of around 6%.
Increasing instances of cancer among the general population and rising healthcare expenditure are major trends driving this market.
The research predicts the APAC market to exhibit the highest CAGR over the next ten years.
Growing preference for liquid biopsy due to its benefits related to intra- and inter-tumor heterogeneity is fueling its demand.
Prime players like Abbott Laboratories, Roche Holding A.G., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Luminex Corporation, and Myriad Genetics Inc. are major market players.
North America is anticipated to account for nearly 40% of the global market share in terms of revenue.
Demand for liquid biopsy is anticipated to surge at a CAGR of around 9% over the next ten years.
Very less awareness on blood cancer diagnostics and complex diagnostic tests & procedures are some of the factors that are expected to restrain market growth to some extent.
- Related Reports -
Natural Flavor Carrier Market
Natural Flavor Carrier Market is projected to grow at steady CAGR rate during 2018-2028. Clean Label...
Natural Food Color Market
Natural Food Color Market is poised to reach US$ 17 Billion, over 7% CAGR from 2021 to 2031. Rising ...
Natural Cold, Cough, and Sore Throat Remedies Market
[170 Pages Report] Natural Cold, Cough, and Sore Throat Remedies Market research report categorizes ...
Natural Gelling Agents Market
Natural Gelling Agents Market is forecast to reach a valuation of US$ 6.33 Bn by 2032. Gelatin as a ...
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.